Caris Life Sciences study finds AI tool could guide pancreatic cancer treatment choice

Caris Life Sciences (Nasdaq:CAI), the Nasdaq-listed Techbio company, has published a study describing an artificial intelligence (AI) tool designed to help doctors choose first-line treatment for ...

Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer

Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced the publication of a study in npj Precision Oncology describing the development and validation of an AI-driven approach ...
Business Wire

Builds Bio+ Releases New York / London Life Sciences Study Tour Research Report

NEW YORK--(BUSINESS WIRE)--Builds Bio+, the premier life science membership organization that connects all segments of the life sciences ecosystem across major regional clusters, today announced the ...
Business Wire

Builds Bio+ Releases New York / London Life Sciences Study Tour Research Report

Regional life science subclusters have formed across all of NYC’s boroughs, serving as hubs for innovation and collaboration. Similarly, regional subclusters are developing across London, mirroring ...